Skip to main content
Market intelligence
CHEHealthcare

Chemed Corp. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 21, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 21, 2026Spencer S Leeexecutive vice presidentSale1,000$541.04$541,040
Aug 21, 2026Kevin J Mcnamarapresident and CEOSale2,000$541.16$1,082,320
Aug 3, 2026Kevin J Mcnamarapresident and CEOSale2,000$539.51$1,079,020